Literature DB >> 10753641

Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein.

N Arai1, A Ström, J J Rafter, J A Gustafsson.   

Abstract

Knowledge regarding the expression of the recently cloned estrogen receptor beta (ERbeta) in colonic mucosa is limited. In this study, we demonstrated that five human colon cancer cell lines, HT29, Colo320, Lovo, SW480, and HCT116, expressed ERbeta mRNA, but lacked ERalpha mRNA. Results from a cell growth assay demonstrated that these colon cancer cells were not influenced by estrogen, while genistein possessed slight growth inhibitory effects on HT29, Colo320 and Lovo cells at 10 microM, at which concentration is stimulated the growth of ERalpha-positive human breast cancer MCF-7 cells. Tamoxifen inhibited the growth of HT29 and Colo320 cells, dose-dependently, as well as MCF-7 cells. A transfected reporter plasmid containing a vitellogenin estrogen response element could be activated by estradiol in Colo320 cells. Taken together with previous reports, these data suggest that ERalpha and ERbeta may have different biological functions in colon cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753641     DOI: 10.1006/bbrc.2000.2444

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  Estrogens regulate the expression of NHERF1 in normal colon during the reproductive cycle of Wistar rats.

Authors:  F Darío Cuello-Carrión; Mariana Troncoso; Elina Guiñazu; Susana R Valdez; Mariel A Fanelli; Daniel R Ciocca; Erica L Kreimann
Journal:  Histochem Cell Biol       Date:  2010-11-16       Impact factor: 4.304

Review 2.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Potential value of estrogen receptor beta expression in colorectal carcinoma: interaction with apoptotic index.

Authors:  Hosam Ghazy Elbanna; Mohamed Awad Ebrahim; Amr Medhat Abbas; Khaled Zalata; Maha Abo Hashim
Journal:  J Gastrointest Cancer       Date:  2012-03

Review 4.  Phenylpropanoids in radioregulation: double edged sword.

Authors:  Wanyeon Kim; Ki Moon Seong; BuHyun Youn
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

5.  Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.

Authors:  Li-Zong Shen; Yi-Bing Hua; Xue-Ming Yu; Qing Xu; Tao Chen; Jian-Hua Wang; Wen-Xi Wu
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line.

Authors:  Maria Notarnicola; Caterina Messa; Antonella Orlando; Benedetta D'Attoma; Valeria Tutino; Rosemary Rivizzigno; Maria Gabriella Caruso
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

7.  Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.

Authors:  Myoung Sook Kim; Cinthia Lebron; Jatin K Nagpal; Young Kwang Chae; Xiaofei Chang; Yiping Huang; Tony Chuang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; Joseph A Califano; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

Review 8.  Oestrogen and colorectal cancer: mechanisms and controversies.

Authors:  Paul A Foster
Journal:  Int J Colorectal Dis       Date:  2013-01-15       Impact factor: 2.571

9.  Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.

Authors:  Kristi L Hoffman; Seth P Lerner; Carolyn L Smith
Journal:  Horm Cancer       Date:  2012-09-11       Impact factor: 3.869

10.  Impact of surgical extent and sex on the hepatic metastasis of colon cancer.

Authors:  Liat Sorski; Ben Levi; Lee Shaashua; Elad Neeman; Marganit Benish; Pini Matzner; Aviad Hoffman; Shamgar Ben-Eliyahu
Journal:  Surg Today       Date:  2013-11-06       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.